Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 851 to 875 of 2422

TitleReference numberPublishedLast updated
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Surgical site infections: prevention and treatmentNG125
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Gilteritinib for treating relapsed or refractory acute myeloid leukaemiaTA642
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643
Entrectinib for treating NTRK fusion-positive solid tumoursTA644
Deep brain stimulation for refractory epilepsy in adultsIPG678
Implanted vagus nerve stimulation for treatment-resistant depressionIPG679
Healthy.io test for home testing of urine albumin to creatinine ratioMIB221
pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysmsMIB222
Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndromeMIB223
Decision making and mental capacityQS194
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Transcranial magnetic stimulation for obsessive-compulsive disorderIPG676
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseIPG677
Renal and ureteric stonesQS195
Artificial iris insertion for acquired aniridiaIPG674
Artificial iris insertion for congenital aniridiaIPG675
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritisES29
Specialist neonatal respiratory care for babies born pretermQS193
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemicMIB219
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634

Results per page

  1. 10
  2. 25
  3. 50
  4. All